CMT Asset Management’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-117,700
Closed -$28.6M 180
2017
Q2
$28.6M Buy
117,700
+13,500
+13% +$3.17M 1.9% 11
2017
Q1
$24.9M Sell
104,200
-32,800
-24% -$7.64M 2.1% 12
2016
Q4
$28.8M Buy
137,000
+9,400
+7% +$1.95M 1.35% 26
2016
Q3
$29.4M Sell
127,600
-53,300
-29% -$13M 1.35% 23
2016
Q2
$41.8M Buy
180,900
+2,700
+2% +$623K 2.11% 8
2016
Q1
$47.8M Buy
178,200
+143,800
+418% +$41.2M 3.2% 2
2015
Q4
$10.8M Buy
+34,400
New +$10.2M 0.55% 48

Other funds holding AGN

CMT Asset Management's AGN Position: Q1 2017 in Review

CMT Asset Management sold out of Allergan plc (AGN) in Q1 2017, closing a stake of 7,985 shares — an estimated $1.86M sold.

CMT Asset Management first reported a position in AGN in Q4 2015 and held it in 2 quarters. The position peaked at $3.34M in Q4 2015. 1,104 funds tracked by Wall St. Rank hold AGN as of Q1 2017.

  • CMT Asset Management reported no remaining Allergan plc position as of Q1 2017 after selling out during the quarter.
  • CMT Asset Management sold 7,985 Allergan plc shares in Q1 2017, an estimated $1.86M.
  • CMT Asset Management first reported a position in Allergan plc in Q4 2015 and held it in 2 quarters.
  • CMT Asset Management's Allergan plc position peaked at $3.34M in Q4 2015.
  • 1,104 funds tracked by Wall St. Rank held Allergan plc as of Q1 2017.

Based on CMT Asset Management's 13F filing for Q1 2017, filed 15 May 2017.